![William Pao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Pao
Direttore/Membro del Consiglio presso
IMMUNOCORE HOLDINGS PLC
Patrimonio netto: - $ in data 31/05/2026
Profilo
William Pao is the founder of Revelio Therapeutics, Inc., founded in 2024, where he holds the title of Chief Executive Officer.
Dr. Pao is also the founder of My Cancer Genome.
Current jobs include Director at Transcelerate Biopharma, Inc., Director at Obsidian Therapeutics, Inc., Director at Alentis Therapeutics AG, and Independent Non-Executive Director at Immunocore Holdings Plc starting in 2025.
Former jobs include Professor and Director of the Hematology & Oncology Division at Vanderbilt University, Director at the American Association for Cancer Research, Director of Personalized Cancer Medicine at The Vanderbilt-Ingram Cancer Center, Chief Development Officer and Executive Vice President at Pfizer Inc. from 2022 to 2023, and Head of Pharma Research & Early Development at Roche Holding AG and F.
Hoffmann-La Roche Ltd. from 2014 to 2022.
Education includes undergraduate studies at Harvard University and a doctorate from Yale University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di William Pao
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Direttore/Membro del Consiglio | 25/02/2025 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Direttore/Membro del Consiglio | - |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Direttore/Membro del Consiglio | - |
Alentis Therapeutics AG
 Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Direttore/Membro del Consiglio | - |
Launchpad Therapeutics, Inc.
 Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | Amministratore Delegato | 01/05/2024 |
Precedenti posizioni note di William Pao
| Società | Posizione | Fine |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 15/08/2023 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 18/03/2022 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/03/2022 |
My Cancer Genome | Fondatore | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di William Pao
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
38
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
The Vanderbilt-Ingram Cancer Center
 The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services Engages in prevention, diagnosis and treatment of cancer | Health Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Alentis Therapeutics AG
Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Launchpad Therapeutics, Inc.
Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | Commercial Services |
My Cancer Genome | Electronic Technology |
